Prestige Consumer Healthcare (PBH) Payables (2011 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Payables came in at $42.9 million in Q4 2025, up 120.17% year-on-year from $19.5 million in Q4 2024, and up 2.44% quarter-over-quarter from $41.9 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Payables (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Payables history runs 15 years deep, the most recent figure standing at $42.9 million for Q4 2025.
- On a quarterly basis, Payables rose 120.17% year-over-year to $42.9 million in Q4 2025; TTM through Dec 2025 was $42.9 million, a 120.17% increase from a year earlier, with the FY2025 full-year figure at $18.9 million, down 51.45% from the prior year.
- Payables rose to $42.9 million in Q4 2025 per PBH's latest filing, from $41.9 million in the prior quarter.
- Across five years, Payables topped out at $64.3 million in Q4 2022 and bottomed at $18.9 million in Q1 2025.
- The 5-year median for Payables is $41.0 million (2021), against an average of $42.4 million.
- Biggest YoY gain for Payables was 120.17% in 2025; the steepest drop was 51.45% in 2025.
- Year by year, Payables stood at $40.1 million in 2021, then surged by 60.22% to $64.3 million in 2022, then slumped by 38.78% to $39.3 million in 2023, then slumped by 50.42% to $19.5 million in 2024, then soared by 120.17% to $42.9 million in 2025.
- Per Business Quant, the three latest PBH Payables figures stand at $42.9 million (Q4 2025), $41.9 million (Q3 2025), and $22.2 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 731.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 8.82 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 42.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 42.95 Mn |
| Sep 30, 2025 | 41.92 Mn |
| Jun 30, 2025 | 22.21 Mn |
| Mar 31, 2025 | 18.93 Mn |
| Dec 31, 2024 | 19.51 Mn |
| Sep 30, 2024 | 31.17 Mn |
| Jun 30, 2024 | 39.56 Mn |
| Mar 31, 2024 | 38.98 Mn |
| Dec 31, 2023 | 39.34 Mn |
| Sep 30, 2023 | 44.38 Mn |
| Jun 30, 2023 | 57.86 Mn |
| Mar 31, 2023 | 62.74 Mn |
| Dec 31, 2022 | 64.25 Mn |
| Sep 30, 2022 | 56.20 Mn |
| Jun 30, 2022 | 58.11 Mn |
| Mar 31, 2022 | 55.76 Mn |
| Dec 31, 2021 | 40.10 Mn |
| Sep 30, 2021 | 38.05 Mn |
| Jun 30, 2021 | 30.96 Mn |
| Mar 31, 2021 | 45.98 Mn |